Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

ZLB

Class 40Status: Registered
Application Number1268193
Trademark Status
Registered
Trademark Class40
Trademark DescriptionTREATMENT OF BIOLOGICAL PRODUCTS NAMELY CUSTOM MANUFACTURING AND FRACTIONATION OF BLOOD, CUSTOM MANUFACTURING AND MANUFACTURE OF VACCINES AND PHARMACEUTICALS, TREATMENT OF BIOLOGICAL PRODUCTS NAMELY IRRADIATION OF SERUM, CELL CULTURES, MEDIA AND REAGENTS FALLING IN CLASS 40.
Application Date2004-02-23
Journal No.1328-1
Journal Date2005-02-07
Proprietor NameZLB BIOPLASMA AG
User Details2014-02-23

Identical Trademarks

Similar trademarks found for this brand

2 found
BrandClassStatus
ZLB40Registered
ZLB5Registered
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about ZLB.

What is the status of trademark application 1268193?
The current status of trademark application 1268193 for ZLB is Registered.
What is the trademark class of ZLB?
ZLB is registered under trademark class 40.
Who is the proprietor of ZLB?
The proprietor of ZLB is ZLB BIOPLASMA AG.
When was trademark application 1268193 filed?
Trademark application 1268193 for ZLB was filed on 2004-02-23.